Navigation Links
Joint Replacement Consumer Awareness Campaign Endorsed by Prominent Orthopaedic Scientist
Date:5/24/2009

Leading joint replacement scientist says the BoneSmart.org consumer awareness campaign extends the mission statement of surgeons and adds great valuable to prospective joint patients.

(PRWEB) May 24, 2009 -- Dr. Ian Clarke, medical researcher and founder of the Peterson Tribology Laboratory at Loma Linda University, has had a research career involving the wear phenomena of joint replacement bearings. He has joined the BoneSmart.org global consumer awareness campaign to help improve access to information for candidates for hip replacement and knee replacement surgery.

By providing insight into traditional and alternative materials used in modern joint replacement surgery, the BoneSmart® campaign empowers patients to learn about the options available to them for knee replacement or hip replacement surgery, and to initiate informed discussions about their options with their surgeons.

In his research, Dr. Clarke studies the wear performance of hip and knee joints using special joint-simulation machines. The materials he studies are at the cutting edge of today's technology, including the latest polyethylene, ceramic and metal alloys for hip and knee joints. The results of his studies provide surgeons and patients alike with information that they can use to choose the right materials.

He believes that timely information about current issues and latest technologies is essential to joint replacement consumers, and that the BoneSmart® campaign helps achieve this aim. The Bonesmart website is continually updated and has easily accessible information on its website - including a moderated, online forum for joint replacement candidates and post-operative patients.

Dr. Clarke's partnership with BoneSmart.org, he says, is a "natural extension" of the mission statement of worldwide surgeons and health professionals.

"Our mission statement for 13 years has been to perform the best research in hip and knee joints and to publish our studies worldwide to surgeons and health professionals. This we have done in many professional journals. However we have not reached out to patients except by educational materials to their surgeons. With BoneSmart.org's technology and vision, patient access becomes a natural extension of our mission statement."

Dr. Ian C. Clark will be contributing to the BoneSmart.org campaign through his biomaterials expertise, attention to hip replacement and knee replacement articles published by the campaign and his involvement in the presentation of biomaterials on the website.

About BoneSmart.org

BoneSmart.org is a National Public-Awareness Campaign for Candidates of Hip Replacement Surgery and Knee Replacement Surgery. The BoneSmart® National Consumer Awareness Campaign's mission is to raise patient awareness of the options available to persons diagnosed as a hip replacement or knee replacement candidates by providing an Internet portal for awareness of the latest advances in joint replacement materials, their longevity and suitability for various applications. With this information the potential patient may be better informed when discussing options with his or her surgeon.

# # #

Read the full story at http://www.prweb.com/releases/knee/replacement/prweb2333584.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related medicine news :

1. MIT is pleased to announce that it has signed the Joint Venture agreement with its Chinese partners and has received an initial order of 120 units for Animal vaccination
2. Winner Medical Establishes Joint Venture With West China Hospital in Chengdu, China
3. Joint Statement from AHCA, NCAL, and the Alliance on the Obama Administrations FY 2010 Budget
4. Bausch & Lomb and 20/10 Perfect Vision Finalize Refractive Surgery Joint Venture
5. Dr. Michael B. Cates Takes Leadership Role on AVMAs One Health Joint Steering Committee
6. Joint Commission Awards TeamHealth Teleradiology Second Consecutive Gold Seal of Approval(TM)
7. Specialists On Call Renews Joint Commission Accreditation
8. Female hormone cycle affects knee joints
9. Coalition to Salute Americas Heroes(TM) Applauds Presidents Announcement to Create Joint Virtual Lifetime Records
10. Study assesses new surgical procedure for regenerating cartilage in damaged knee joints
11. Hahnemann University Hospital Awarded Certification From the Joint Commission for Ventricular Assist Devices
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Joint Replacement Consumer Awareness Campaign Endorsed by Prominent Orthopaedic Scientist
(Date:4/28/2017)... ... ... enough sleep affects much more than energy – it also has mental and physical benefits. ... motor reaction time, which can increase the risk of having a car accident. , ... the NSF to help you sleep better and feel better:, , ...
(Date:4/28/2017)... ... April 28, 2017 , ... ... http://www.wiredlifesolutions.com , “Computers are everywhere and they’re here to stay,” said ... Global Climate Change and Your Health on Voice America sponsored by Nature’s Tears® ...
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... The ... board members and officers for 2017-2018. The annual board election process has been in ... a volunteer basis. , Thomas C. Dickerson, Ed.D., FACHE, succeeds Jim Hamilton, MHA, CMM, ...
(Date:4/28/2017)... ... April 28, 2017 , ... Children and adolescents who ... experiences than children in the general population. That’s because foster care is designed ... family challenges. While no fault of their own, youth who have experienced trauma ...
(Date:4/28/2017)... Harbor, Md. (PRWEB) , ... April 28, 2017 ... ... Care Association of America (UCAOA) and College of Urgent Care Medicine will host ... 2017 workshops, sessions and speakers will help those in the industry adapt to ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... 2017  AbbVie (NYSE: ABBV), a global biopharmaceutical ... chronic hepatitis C virus (HCV) infected patients with ... compensated cirrhosis (Child-Pugh A) achieved sustained virologic response ... its investigational, pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). These ... 12 weeks of G/P treatment without ribavirin. Patients ...
(Date:4/20/2017)... Sweden , April 20, 2017 ... NEVPF) ("NeuroVive") today announced positive preclinical results ... preclinical compound for non-alcoholic steatohepatitis (NASH), in ... NV556 has previously shown ... NASH model. Today, NeuroVive,s scientists present novel ...
(Date:4/19/2017)... , April 19, 2017 Cardiology devices segment ... projected period The Cardiology Devices segment is likely ... US$ 15 Mn in 2018 over 2017. By the end ... market valuation close to US$ 700 Mn, expanding at a ... segment dominated the Asia Pacific reprocessed ...
Breaking Medicine Technology: